| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -36% |
| 3Y CAGR | +1% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -20% |
| 3Y CAGR | 0% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,703.80 -36.60 (0.77%) | 21,702.50 | 29.52 | 5.16 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,517.20 -23.50 (0.92%) | 19,323.31 | 28.5 | 5.39 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,106.50 -29.50 (0.41%) | 17,802.75 | 104.95 | 20.4 | ||
Natco PharmaNATCOPHARM | ₹853.80 -3.80 (0.44%) | 15,371.21 | 13.43 | 1.67 |